author-photo

K. C. Anderson

Memorial Sloan Kettering Cancer Center

69

Papers

3893

Citations

Citation Trend

Filter By

Papers (54) Sort By

Journal Conference Others

THE IMPACT OF RESPONSE KINETICS FOLLOWING INITIAL THERAPY FOR MULTIPLE MYELOMA IN THE ERA OF NOVEL AGENTS: PF593

2019
Show All
- Source
- Cite
- Save
Citations (0)
Blockade of deubiquitylating enzyme Rpn11 triggers apoptosis in multiple myeloma cells and overcomes bortezomib resistance

2017 Oncogene
Show All
- Source
- Cite
- Save
Citations (48)
Lenalidomide and bortezomib induce osteoclast cytotoxicity and decrease BAFF secretion in osteoclasts in human multiple myeloma: Clinical implications

2016 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)
Transplant Eligible Maintenance

2015 Clinical Lymphoma, Myeloma & Leukemia
Show All
- Source
- Cite
- Save
Citations (0)
HDAC inhibition by LBH589 affects the phenotype and function of human myeloid dendritic cells

2011 Leukemia
Show All
- Source
- Cite
- Save
Citations (77)
A unique three-dimensional SCID-polymeric scaffold (SCID-synth-hu) model for in vivo expansion of human primary multiple myeloma cells.

2011 Leukemia
Show All
- Source
- Cite
- Save
Citations (95)
Phase III intergroup study of lenalidomide versus placebo maintenance therapy following single autologous stem cell transplant (ASCT) for multiple myeloma (MM): CALGB 100104.

2010 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (78)
A627 Alternate Splicing Is Frequently Observed in Myeloma and Has Impact on Clinical Outcome

2009 Clinical Lymphoma, Myeloma & Leukemia
Show All
- Source
- Cite
- Save
Citations (0)
TNF-a, retinoid acid and STAT4 pathways are differentially regulated by the HDAC inhibitors, SAHA, TSA and Sirtinol in Waldenstrom's Macroglobulinemia

2009 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Role of selectins in the pathogenesis of multiple myeloma

2009 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)